Temple University Health loses top execs amid restructuring

https://www.beckershospitalreview.com/hospital-management-administration/temple-university-health-loses-top-execs-amid-restructuring.html

Image result for temple university health system

Philadelphia-based Temple University Health System President and CEO Larry Kaiser, MD, confirmed in a letter to colleagues that two top executives plan to depart and their roles will be eliminated, The Inquirer reports.

The Jan. 23 letter, obtained by The Inquirer, states that the health system’s CMO Susan Freeman, MD, and Chief Administrative Officer Alan Rosenberg, are departing and their roles will be eliminated.

Dr. Kaiser, who also serves as dean of the affiliated Lewis Katz School of Medicine, wrote in the letter that Philadelphia-based Temple University Hospital CEO Verdi DiSesa, MD, and its CMO will also step down from their positions. He did not specify what the individuals’ new roles would be.

“I ask that all of you work with me and the leadership team as we move forward with our ongoing restructuring that will allow us to continue to provide superb clinical care for the population we serve and an outstanding education for our students,” Dr. Kaiser wrote in the letter.

Temple University Health System is working with a chief restructuring officer to become more financially sustainable. For the three months ended Sept. 30, 2018, the system reported a net loss of $11.63 million.

To access the full report, click here.

 

Temple University Health System hires restructuring officer for potential sale

https://www.beckershospitalreview.com/hospital-transactions-and-valuation/temple-university-health-system-hires-restructuring-officer-for-potential-sale.html

Image result for temple university hospital

Philadelphia-based Temple University’s board of trustees announced June 20 the institution will hire a chief restructuring officer for its affiliated health system, and is considering the potential sale of two of its hospital assets, according to The Inquirer.

Temple University President Richard Englert and Temple University Health System CEO Larry Kaiser, MD, said in a joint statement to the community TUHS “faces significant operational and financial challenges. More must be done to maintain a viable and sustainable healthcare enterprise in a highly competitive and volatile market,” according to the report.

Officials also said the health system is considering the sale of Jeanes Hospital and the Fox Chase Cancer Center, both in Philadelphia.

The Inquirer reports Temple University Health System incurred a net loss of $31.1 million in the nine months ended March 31, compared to the system’s $19.9 million loss the year prior.

 

INTERIM HEALTHCARE CHIEF RESTRUCTURING OFFICER (CRO) – A CEO’S MOST POWERFUL ALLY DURING TRANSFORMATION

http://www.jacksonexecutives.com/2016/07/19/interim-healthcare-chief-restructuring-officer-cro/

Interim CROs

When the survival of the organization is at stake and things have reached crisis proportions, traditional chief restructuring officers are a solid option and best fit. A CRO immediately brings credibility and objectivity to the restructuring process, while stabilizing the ranks and quickly devising a plan to lead the turnaround.

Confidence builders and skilled communicators, they bring deep financial and industry-specific experience. This allows them to identify the root cause(s) of under-performing organizations, and to work in concert with CEOs to transform organizations from the inside out using strong strategic and negotiation skills.